tiprankstipranks
Rekah Pharmaceutical Industry Ltd. (IL:REKA)
TASE:REKA
Israel Market
REKA
Rekah
RESEARCH TOOLSreports

Rekah (REKA) Income Statement

0 Followers

Rekah Income Statement

Last quarter (Q4 2025), Rekah's total revenue was ₪76.91M, an increase of 0.98% from the same quarter last year. In Q4, Rekah's net income was ₪-6.29M. See Rekah’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₪ 300.99M₪ 321.71M₪ 321.66M₪ 292.39M₪ 263.95M
Gross Profit
₪ 58.17M₪ 71.95M₪ 80.20M₪ 78.70M₪ 65.16M
Operating Expenses
₪ 64.43M₪ 55.58M₪ 77.25M₪ 65.45M₪ 51.02M
Depreciation and Amortization
₪ 30.77M₪ 32.66M₪ 23.12M₪ 27.48M₪ 22.86M
EBITDA
₪ 24.51M₪ 47.30M₪ 26.03M₪ 40.73M₪ 35.77M
Operating Income
₪ -6.26M₪ 16.37M₪ 2.96M₪ 13.25M₪ 14.14M
Other Income/Expenses
₪ -4.93M₪ -8.44M₪ -9.96M₪ -12.90M₪ -6.43M
Pretax Income
₪ -11.20M₪ 7.93M₪ -7.05M₪ 357.00K₪ 7.71M
Net Income
₪ -18.07M₪ 6.21M₪ -6.91M₪ -2.04M₪ 6.62M
Per Share Metrics
Basic EPS
₪ -1.58₪ 0.52₪ -0.61₪ -0.18₪ 0.58
Diluted EPS
₪ -1.58₪ 0.52₪ -0.61₪ -0.18₪ 0.58
Weighted Average Shares Outstanding
 11.41M 11.98M 11.33M 11.34M 11.41M
Weighted Average Shares Outstanding (Diluted)
 11.41M 11.98M 11.41M 11.41M 11.41M
Currency in ILS

Rekah Earnings and Revenue History